Headlamp Health today announced the launch of Lumos AI®, a comprehensive decision-support platform designed to help drug developers address the complexity that has long stalled neuroscience progress.

Earable ® Neuroscience, creator of the three-time CES Innovation Award-winning FRENZ Brainband, today announced two major ...

A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases - ...

Today, on the opening day at CES, Neurable announced it’s working with HP Inc.’s HyperX gaming brand to develop an ...

BrainsWay’s SWIFT depression protocol consists of an acute phase of five treatment sessions (ten minutes each) per day for ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people are already affected worldwide, and the number is continually climbing. Men ...

KeifeRx, announced that Chief Executive Officer Chris Hoyt will be speaking at two leading investor events during J.P. Morgan Healthcare Conference week. WASHINGTON, DC, UNITED STATES, January 5, 2026 ...

A model predicting the point at which AI could develop a ‘superintelligence’ and develop autonomously has been delayed ...

Explore how AI startups are transforming earbuds into powerful AI devices that can record meetings, provide real-time ...

Just before Christmas, the US Department of the Interior announced that all five of the country’s large-scale offshore wind ...

Artificial intelligence AI has taken over almost every sector, including devices or gadgets like computing, mobile, and chips ...

Researchers Brad Theilman, center, and Felix Wang, behind, unpack a neuromorphic computing core at Sandia National ...